NuVasive NUVA
-
Closing the DOJ Investigation of INFUSE Comes as Good News to Medtronic
… treatment. Additionally, smaller competitors such as NuVasive NUVA have introduced new biologic products that compete with ..... be bundled with its hardware and instrument systems, NuVasive has been able to attract more spinal surgeons to embrace …
-
4 Outperforming Healthcare Stocks With Strong Sales Trends
By Kapitall : Do you like to invest with a stock's momentum trends? For ideas on how to start your own momentum search, we ran a screen. We began by screening the healthcare sector for stocks that have outperformed the market over the last quarter, with quarterly performance above 20%. We then ...
-
Spinal implant maker NuVasive ([[ NUVA ]] +17%) pops after its Q1 results easily beat estimates, coming in at the high end of the expected range. Revenue jumped 21% Y/Y on strong sales of its minimally ...
Spinal implant maker NuVasive ( NUVA +17% ) pops after its Q1 results easily beat estimates, coming in at the high end of the expected range. Revenue jumped 21 …
-
Premarket gainers: [[PLXT]] +65%. [[PFCB]] +30%. [[ NUVA ]] +18%. [[CAR]] +14%. [[CETV]] +15%. [[VECO]] +13%. [[HUN]] +10%. [[YGE]] +8%. [[LYG]] +7%. [[SHLD]] +7%. [[CAKE]] +6%. [[TSL]] +6%. [[HTZ]] ...
Premarket gainers: PLXT +65% . PFCB +30% . NUVA +18% . CAR +14% . CETV +15% . VECO +13% . HUN +10% . YGE +8% . LYG +7% . SHLD +7% . CAKE +6% . TSL +6% . HTZ …
-
Biotechnology And Drugs Stocks To Watch For Next Week
By StockPandit : Next week is a busy earnings season, with many quarterly earnings releases scheduled and a bunch of stocks to watch. However, my focus is on biotechnology and drugs stocks that have earnings due in the next week. This article provides earnings previews on several stocks to consider
-
NuVasive ([[ NUVA ]] +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the fundamentals of the slumping market for spine products have turned a corner. The firm says NUVA is well ...
NuVasive ( NUVA +7.2% ) shares are upgraded to Outperform by JMP Securities on signs ..... slumping market for spine products have turned a corner. The firm says NUVA is well positioned to benefit from what should prove a long-term trend …
-
NuVasive Has Been Bloodied, But The Growth Story Isn't Broken
… small-cap orthopedics company NuVasive ( NUVA ). Not only has the company gotten ..... meaningful new products on the horizon, NuVasive looks like an interesting rebound ..... analysts have been trimming numbers on NuVasive , the company still delivered pretty …
-
Sparton Q2 Results Power Past Siemens Medical Speed Bump
Sparton Corporation (NYSE: SPA ), a $218MM LTM revenue company that designs, develops and manufactures complex electronic and electromechanical products and subassemblies (and provides related services) for the Medical, Military & Aerospace, and Industrial & Instrumentation markets, just announced
-
Court denies motion to halt sales of NuVasive spinal products
Jan 25 (Reuters) - A federal court tentatively denied a motion to stop sales of NuVasive Inc's spinal products that a jury had earlier found to have infringed Medtronic Inc's patents, sending...
-
NuVasive ([[ NUVA ]] -3.2%) gives back a little today, despite being upgraded to Above Average at Caris. The stock has ramped nearly 15% higher over the past two days, following an earlier upgrade by ...
NuVasive ( NUVA -3.2% ) gives back a little today, despite being upgraded to Above Average at Caris. The stock has ramped nearly 15% higher over the past two days, following an earlier upgrade by ThinkEquity and an upbeat preliminary FY11 earnings report. Post your comment!